Vietnam MOH registration 240002954/PCBB-HN

Amylase Quantitative Testing Drug

VN: Thuốc thử xét nghiệm định lượng amylase
Vietnam flagVietnam·Risk Class TBYT Loại B·Amylase2·Abbott Ireland Diagnostics Division·Registered Oct 30, 2024
Registration details
Analysis ID
240002954/PCBB-HN
Submission ID
000.00.19.H26-241015-0004
Product Type
Amylase2
Company information
Technical details
Intended Use
Amylase2 test is used to quantify amylase in human serum, plasma, or urine on the Alinity c analyzer. Amylase2 test is primarily used to support the diagnosis and treatment of pancreatitis (inflammation of the pancreas).
Dates and status
Registration Date
Oct 30, 2024
Companies making similar products

Companies providing products similar to "Amylase Quantitative Testing Drug"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Amylase Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002954/PCBB-HN and manufactured by Abbott Ireland Diagnostics Division. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbott Ireland Diagnostics Division, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices1 Competitors2 Recent Registrations